NYSE:RAD - Rite Aid Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $7.50
  • Forecasted Upside: 10.95 %
  • Number of Analysts: 2
  • Breakdown:
  • 2 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$6.76
▼ -0.09 (-1.31%)

This chart shows the closing price for RAD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Rite Aid Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RAD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RAD

Analyst Price Target is $7.50
▲ +10.95% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Rite Aid in the last 3 months. The average price target is $7.50, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 10.95% upside from the last price of $6.76.

This chart shows the closing price for RAD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Sell

The current consensus among 2 polled investment analysts is to sell stock in Rite Aid. This Sell consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 3 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 3 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 3 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 3 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 3 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 3 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 3 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 2 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/3/2022Deutsche Bank AktiengesellschaftBoost Price Target$2.00 ➝ $4.00High
4/18/2022Deutsche Bank AktiengesellschaftBoost Price Target$1.00 ➝ $2.00Low
4/7/2022Deutsche Bank AktiengesellschaftDowngradeHold ➝ SellHigh
10/20/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$13.00 ➝ $15.00High
9/24/2021Evercore ISIInitiated CoverageSell$11.00Medium
6/25/2021JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$21.00 ➝ $12.00High
6/22/2021Deutsche Bank AktiengesellschaftLower Price TargetHold$27.00 ➝ $18.00High
6/9/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldMedium
3/25/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$17.00 ➝ $27.00High
12/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$9.00 ➝ $17.00High
9/25/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$18.00 ➝ $9.00High
9/24/2020Evercore ISIBoost Price TargetUnderperform$4.00 ➝ $6.00High
6/26/2020JPMorgan Chase & Co.Boost Price TargetNeutral$12.00 ➝ $17.00High
6/26/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$12.00 ➝ $18.00High
4/17/2020Deutsche Bank AktiengesellschaftUpgradeSell ➝ Hold$12.00Low
2/27/2020GuggenheimUpgradeSell ➝ NeutralHigh
12/23/2019Deutsche Bank AktiengesellschaftBoost Price TargetSell$5.00 ➝ $12.00High
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageSell$5.00High
8/12/2019Evercore ISIReiterated RatingSellHigh
4/18/2019GuggenheimReiterated RatingSell ➝ SellHigh
12/20/2018Loop CapitalLower Price TargetHold$27.00 ➝ $20.00High
9/28/2018Loop CapitalSet Price TargetHold$20.00Low
9/24/2018Royal Bank of CanadaSet Price TargetHold$20.00Low
9/6/2018The Goldman Sachs GroupInitiated CoverageSell ➝ Sell$20.00High
8/13/2018CowenDowngradeOutperform ➝ Market Perform$47.00 ➝ $120.00High
8/9/2018MizuhoReiterated RatingHold$40.00Low
6/28/2018CowenReiterated RatingBuy$47.00High
4/17/2018MizuhoReiterated RatingHoldMedium
1/4/2018Evercore ISIInitiated CoverageUnderperform ➝ Underperform$30.00Medium
12/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold$45.00Medium
10/25/2017Royal Bank of CanadaSet Price TargetHold$40.00N/A
10/7/2017MizuhoSet Price TargetHold$40.00N/A
10/6/2017MizuhoLower Price TargetNeutral ➝ Neutral$59.00 ➝ $45.00N/A
10/2/2017GuggenheimReiterated RatingNeutral$40.00Low
9/29/2017Loop CapitalReiterated RatingHold ➝ Hold$50.00 ➝ $40.00High
9/19/2017Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform$50.00High
9/11/2017Loop CapitalInitiated CoverageHold ➝ Hold$50.00High
7/20/2017MizuhoDowngradeBuy ➝ Neutral$59.00Medium
(Data available from 7/6/2017 forward)

News Sentiment Rating

0.24 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
12/8/2021
  • 9 very positive mentions
  • 19 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
1/7/2022
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
2/6/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
3/8/2022
  • 3 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
4/7/2022
  • 7 very positive mentions
  • 26 positive mentions
  • 13 negative mentions
  • 10 very negative mentions
5/7/2022
  • 4 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/6/2022
  • 6 very positive mentions
  • 24 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
7/6/2022

Current Sentiment

  • 6 very positive mentions
  • 24 positive mentions
  • 6 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Rite Aid logo
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania.
Read More

Today's Range

Now: $6.76
Low: $6.60
High: $6.99

50 Day Range

MA: $6.27
Low: $4.77
High: $8.69

52 Week Range

Now: $6.76
Low: $4.68
High: $19.22

Volume

2,200,433 shs

Average Volume

3,481,256 shs

Market Capitalization

$376.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Frequently Asked Questions

What sell-side analysts currently cover shares of Rite Aid?

The following equities research analysts have issued reports on Rite Aid in the last twelve months: Deutsche Bank Aktiengesellschaft, Evercore ISI, StockNews.com, and TheStreet.
View the latest analyst ratings for RAD.

What is the current price target for Rite Aid?

0 Wall Street analysts have set twelve-month price targets for Rite Aid in the last year. Their average twelve-month price target is $7.50, suggesting a possible upside of 10.9%.
View the latest price targets for RAD.

What is the current consensus analyst rating for Rite Aid?

Rite Aid currently has 2 sell ratings from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe RAD will underperform the market and that investors should sell shares of Rite Aid.
View the latest ratings for RAD.

How do I contact Rite Aid's investor relations team?

Rite Aid's physical mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company's listed phone number is (717) 761-2633 and its investor relations email address is [email protected] The official website for Rite Aid is www.riteaid.com. Learn More about contacing Rite Aid investor relations.